At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods
Munib Mesinovic(Science Oxford), Nathalie Allou, Giri Shan Rajahram(Ministry of Health), Andrew Acker, Barbara Wanjiru Citarella(University of Oxford), Clotilde Allavena(Centre Hospitalier Universitaire de Nantes), Eka Airlangga, Nurul Najmee Abdulkadir, Xin Ci Wong, Takako Akimoto, Senthilkumar Alegesan, Ali Ait Hssain, Shingo Adachi(Angkor Hospital for Children), Saleh Al Ageel, Adam Ali(St Bernard's Hospital), Beatrice Alex(Imperial College London), Younes Ait Tamlihat(Imation (United States)), Marta Alessi(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Piero Olliaro(University of Oxford), Lei Clifton(University of Oxford), Shakeel Ahmed(University Hospital Kerry), Christiana Kartsonaki(University of Oxford), Abdulrahman Al‐Fares(Amiri Hospital), Kate Ainscough, Ernita Akmal, Amal Abrous, Lara Absil, Qabas Alkhafajee, Angela Alberti(Northwell Health), Kévin Alexandre, Cynthia Alegre, Marina Aiello(University of Parma), Huda Alfoudri(Adan Hospital), Laura Merson, Kalaiarasu M. Peariasamy(Ministry of Health), Razi Alalqam(University of Oxford), Tala Al-dabbous, Ryuzo Abe, Diana Adrião, Laurent Abel(Inserm), Imran Ali, Tharwat Aisa(Our Lady of Lourdes Hospital), Frank van Someren Greve(Amsterdam University Medical Centers), Enrico Adriano(University of Parma), Kazali Enagnon Alidjnou, Sheryl Ann Abdukahil, Jeffrey Aliudin, Eman Al Qasim, Elisabeth Adam(Goethe University Frankfurt)
Cited by 10
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry
|The Lancet|2020|945
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721